drugset / Trial / NCT00625859
A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this research study is to look at concentrations of GSK189075, WELLBUTRIN SR and active metabolic products in blood samples when doses of both drugs are taken by mouth. Doses are either taken alone or together. The results will help to determine if doses of GSK189075 and WELLBUTRIN SR can be safely taken together.
Timeline
- Start
- 2008-01-16
- Primary completion
- 2008-04-10
- Completion
- 2008-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 150 mg | Oral |
| Subject | remogliflozin etabonate | Small molecule | 250 mg | — |